Marples D, Frøkiaer J, Dørup J, Knepper M A, Nielsen S
Department of Cell Biology, Institute of Anatomy, University of Aarhus, Denmark.
J Clin Invest. 1996 Apr 15;97(8):1960-8. doi: 10.1172/JCI118628.
Prolonged hypokalemia causes vasopressin-resistant polyuria. We have recently shown that another cause of severe polyuria, chronic lithium therapy, is associated with decreased aquaporin-2 (AQP2) water channel expression (Marples, D., S. Christensen, E.I. Christensen, P.D. Ottosen, and S. Nielsen, 1995. J. Clin. Invest., 95: 1838-1845). Consequently, we studied the effect in rats of 11 days' potassium deprivation on urine production and AQP2 expression and distribution. Membrane fractions were prepared from one kidney, while the contralateral kidney was perfusion-fixed for immunocytochemistry. Immunoblotting and densitometry revealed a decrease in AQP2 levels to 27+/-3.4% of control levels (n=11, P<0.001) in inner medulla, and 34+/-15% of controls (n=5, P<0.05) in cortex. Urine production increased in parallel, from 11+/-1.4 to 30+/-4.4 ml/day (n=11, P<0.01). After return to a potassium-containing diet both urine output and AQP2 labels normalized within 7 d. Immunocytochemistry confirmed decreased AQP2 labeling in principal cells of both inner medullary and cortical collecting ducts. AQP2 labeling was predominantly associated with the apical plasma membrane and intracellular vesicles. Lithium treatment for 24 d caused a more extensive reduction of AQP2 levels, to 4+/-1% of control levels in the inner medulla and 4+/-2% in cortex, in association with severe polyuria. The similar degree of downregulation in medulla and cortex suggests that interstitial tonicity is not the major factor in the regulation of AQP2 expression. Consistent with this furosemide treatment did not alter AQP2 levels. In summary,hypokalemia, like lithium treatment, results in a decrease in AQP2 expression in rat collecting ducts, in parallel with the development of polyuria, and the degree of downregulation is consistent with the level of polyuria induced, supporting the view that there is a causative link.
长期低钾血症会导致抗血管升压素性多尿。我们最近发现,严重多尿的另一个原因——慢性锂治疗,与水通道蛋白-2(AQP2)水通道表达减少有关(马普尔斯,D.,S.克里斯蒂安森,E.I.克里斯蒂安森,P.D.奥托森,以及S.尼尔森,1995年。《临床研究杂志》,95: 1838 - 1845)。因此,我们研究了大鼠11天钾缺乏对尿液生成以及AQP2表达和分布的影响。从一侧肾脏制备膜组分,而对侧肾脏进行灌注固定用于免疫细胞化学研究。免疫印迹和光密度测定显示,内髓质中AQP2水平降至对照水平的27±3.4%(n = 11,P < 0.001),皮质中降至对照水平的34±15%(n = 5,P < 0.05)。尿量同时增加,从11±1.4毫升/天增至30±4.4毫升/天(n = 11,P < 0.01)。恢复含钾饮食后,尿量和AQP2标记在7天内恢复正常。免疫细胞化学证实,内髓质和皮质集合管主细胞中的AQP2标记减少。AQP2标记主要与顶端质膜和细胞内囊泡相关。锂治疗24天导致AQP2水平更广泛降低,内髓质降至对照水平的4±1%,皮质降至4±2%,同时伴有严重多尿。内髓质和皮质中类似程度的数据下调表明,间质张力不是AQP2表达调节的主要因素。与此一致的是,速尿治疗并未改变AQP2水平。总之,低钾血症与锂治疗一样,会导致大鼠集合管中AQP2表达减少,同时伴有多尿的发生,下调程度与诱导的多尿水平一致,支持了两者存在因果关系的观点。